Products found to contain undeclared medicines
|
| |
| Australia: Safety advisory - Slimina weightloss capsules |
| |
The Therapeutic Goods Administration (TGA) is aware that some Australian consumers may have purchased the product Slimina weightloss capsules over the internet. The label of this product claims the ingredients to be 100% herbal in origin. However, analysis undertaken by the TGA Laboratories in Australia has confirmed the presence of therapeutic quantities of sibutramine in these capsules. Consumers are advised that sibutramine was a prescription-only medicine supplied in Australia until it was withdrawn in October 2010 due to safety concerns, particularly in patients with history of cardiovascular disease. Slimina weightloss capsules have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA. If you have purchased Slimina weightloss capsules you are advised to cease using them and discard any remaining product. If you have concerns arising from your use of this product, you should consult your health care practitioner.
Please refer to the following website in TGA for details:
http://www.tga.gov.au/safety/alerts-medicine-slimina-110818.htm
In Hong Kong, the above product is not a registered pharmaceutical product.
Ends/ Friday, August 19, 2011
Issued at HKT 17:30
|
| |
